Literature DB >> 7794389

The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans.

P Rhodes1, A M Leone, P L Francis, A D Struthers, S Moncada, P ] Rhodes PM [corrected to Rhodes.   

Abstract

15N guanidino-labelled L-arginine was infused into fasted human volunteers giving, at equilibrium, a stable 1:10 ratio of 15N to 14N arginine in the plasma. Separate GC-MS assays were used to compare the degree of enrichment of plasma arginine, nitrite and nitrate and thus define the quantitative relationship between the L-arginine:nitric oxide (NO) pathway and the formation of these oxides of nitrogen. 15N nitrite enrichments rose to 8.3% (SD 0.5), five hours after the start of the infusion. In contrast, 15N nitrate enrichments apparently rose to only 1.6% (SD 0.4) at this time. This discrepancy could be explained by our finding that the commonly used Tesch GC-MS nitrate assay is subject to considerable interference from non-nitrate sources in plasma. Taking this into account, nitrate enrichments were similar to those observed for plasma nitrite. These results therefore indicate that the measurement of these compounds in plasma is a valid indicator of NO generation in fasted humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794389     DOI: 10.1006/bbrc.1995.1541

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  40 in total

1.  Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action.

Authors:  T Lauer; M Preik; T Rassaf; B E Strauer; A Deussen; M Feelisch; M Kelm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Changes in nitric oxide release in vivo in response to vasoactive substances.

Authors:  E Nava; N P Wiklund; F J Salazar
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans.

Authors:  S C Erzurum; S Ghosh; A J Janocha; W Xu; S Bauer; N S Bryan; J Tejero; C Hemann; R Hille; D J Stuehr; M Feelisch; C M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

4.  Effects of caffeine on placental total nitrite concentration: A 21-day, vehicle-controlled study in rats.

Authors:  Belgin Alasehirli; Mustafa Cekmen; Muradiye Nacak; Ayse Balat
Journal:  Curr Ther Res Clin Exp       Date:  2005-03

Review 5.  Dietary nitrite and nitrate: a review of potential mechanisms of cardiovascular benefits.

Authors:  Ajay Machha; Alan N Schechter
Journal:  Eur J Nutr       Date:  2011-05-31       Impact factor: 5.614

Review 6.  Nitrite and nitric oxide metabolism in peripheral artery disease.

Authors:  Jason D Allen; Tony Giordano; Christopher G Kevil
Journal:  Nitric Oxide       Date:  2012-03-14       Impact factor: 4.427

7.  The relationship between plasma and salivary NOx.

Authors:  William H Clodfelter; Swati Basu; Crystal Bolden; Patricia C Dos Santos; S Bruce King; Daniel B Kim-Shapiro
Journal:  Nitric Oxide       Date:  2015-04-21       Impact factor: 4.427

Review 8.  Nitrite as regulator of hypoxic signaling in mammalian physiology.

Authors:  Ernst E van Faassen; Soheyl Bahrami; Martin Feelisch; Neil Hogg; Malte Kelm; Daniel B Kim-Shapiro; Andrey V Kozlov; Haitao Li; Jon O Lundberg; Ron Mason; Hans Nohl; Tienush Rassaf; Alexandre Samouilov; Anny Slama-Schwok; Sruti Shiva; Anatoly F Vanin; Eddie Weitzberg; Jay Zweier; Mark T Gladwin
Journal:  Med Res Rev       Date:  2009-09       Impact factor: 12.944

9.  Vascular effects of dietary nitrate (as found in green leafy vegetables and beetroot) via the nitrate-nitrite-nitric oxide pathway.

Authors:  Satnam Lidder; Andrew J Webb
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

10.  L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.

Authors:  S M Bode-Böger; R H Böger; A Galland; D Tsikas; J C Frölich
Journal:  Br J Clin Pharmacol       Date:  1998-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.